Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

Taro-Deferasirox, Dispersible tablets for oral suspension
« Back to list view

Product Information

  • DIN:
    02463520
  • Active Ingredients :
    deferasirox
  • Innovator Name:
    Exjade®
  • Category:
    Iron chelating agent
  • Dosage form:
    Dispersible tablets for oral suspension
  • Strength:
    125 mg
  • Route of Administration:
    Oral
  • Colour:
    Off-white
  • Shape:
    round, flat with beveled edge
  • Markings:
    Debossed with “568” on one side and plain on other side
  • Package size:
    30 bottle
  • UPC Code:
    063691081734
  • Description :
    Off-white, round uncoated tablets, flat with beveled edge, debossed with “568” on one side and plain on other side.
  • Non-medicinal ingredients :
    lactose monohydrate, crospovidone, povidone (K29/32), sodium lauryl sulphate, microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate
Taro-Deferasirox, Dispersible tablets for oral suspension

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02463539
  • Active Ingredients :
    deferasirox
  • Innovator Name:
    Exjade®
  • Category:
    Iron chelating agent
  • Dosage form:
    Dispersible tablets for oral suspension
  • Strength:
    250 mg
  • Route of Administration:
    Oral
  • Colour:
    Off-white
  • Shape:
    round, flat with beveled edge
  • Markings:
    Debossed with “569” on one side and plain on other side
  • Package size:
    30 bottle
  • UPC Code:
    063691081697
  • Description :
    Off-white, round uncoated tablets, flat with beveled edge, debossed with “569” on one side and plain on other side.
  • Non-medicinal ingredients :
    lactose monohydrate, crospovidone, povidone (K29/32), sodium lauryl sulphate, microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate
Taro-Deferasirox, Dispersible tablets for oral suspension

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02463547
  • Active Ingredients :
    deferasirox
  • Innovator Name:
    Exjade®
  • Category:
    Iron chelating agent
  • Dosage form:
    Dispersible tablets for oral suspension
  • Strength:
    500 mg
  • Route of Administration:
    Oral
  • Colour:
    Off-white
  • Shape:
    round, flat with beveled edge
  • Markings:
    Debossed with “570” on one side and plain on other side
  • Package size:
    30 bottle
  • UPC Code:
    063691081673
  • Description :
    Off-white, round uncoated tablets, flat with beveled edge, debossed with “570” on one side and plain on other side.
  • Non-medicinal ingredients :
    lactose monohydrate, crospovidone, povidone (K29/32), sodium lauryl sulphate, microcrystalline cellulose, colloidal silicon dioxide and magnesium stearate
Taro-Deferasirox, Dispersible tablets for oral suspension

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement